Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
14.18
-0.80 (-5.34%)
At close: Feb 21, 2025, 4:00 PM
14.29
+0.11 (0.78%)
After-hours: Feb 21, 2025, 7:30 PM EST
Myriad Genetics Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Myriad Genetics stock have an average target of 22.54, with a low estimate of 13 and a high estimate of 35. The average target predicts an increase of 58.96% from the current stock price of 14.18.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Myriad Genetics stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 2 |
| Buy | 4 | 4 | 4 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 6 | 6 | 6 |
| Sell | 2 | 2 | 2 | 3 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 13 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +104.51% | Feb 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $24 → $14 | Hold | Maintains | $24 → $14 | -1.27% | Jan 30, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $29 → $18 | Strong Buy | Maintains | $29 → $18 | +26.94% | Jan 28, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $20 | Hold | Reiterates | $20 | +41.04% | Jan 16, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $15 → $13 | Sell | Maintains | $15 → $13 | -8.32% | Dec 13, 2024 |
Financial Forecast
Revenue This Year
855.64M
from 753.20M
Increased by 13.60%
Revenue Next Year
883.47M
from 855.64M
Increased by 3.25%
EPS This Year
0.13
from -3.18
EPS Next Year
0.06
from 0.13
Decreased by -57.97%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 885.3M | 937.5M | 1.0B | ||
| Avg | 855.6M | 883.5M | 964.5M | ||
| Low | 819.4M | 808.6M | 835.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.5% | 9.6% | 18.2% | ||
| Avg | 13.6% | 3.3% | 9.2% | ||
| Low | 8.8% | -5.5% | -5.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.16 | 0.21 | 0.68 | ||
| Avg | 0.13 | 0.06 | 0.33 | ||
| Low | 0.12 | -0.18 | -0.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 55.8% | 1,105.0% | ||
| Avg | - | -58.0% | 480.2% | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.